Antibodies for Muscle Loss Reduction
Aequita Bioworks is developing novel therapeutics that preserve lean muscle mass during GLP-1 mediated weight loss.
What We Do
GLP-1 medication doesn't differentiate the loss between muscle or fat. We design biologics that target pathways associated with reduced muscle loss and increased fat loss while using GLP-1 medications.
Work With Us
We're a talented and ambitious team researching cutting edge therapeutics. Interested in joining? See current job opportunities below.